CA Patent

CA2140701A1 — Liposome solutions

Assigned to F Hoffmann La Roche AG · Expires 1995-07-26 · 31y expired

What this patent protects

The invention is concerned with aqueous liposome solutions which contain a .beta.-lactamase inhibitor and, if desired, a .beta.-lactam antibiotic.

USPTO Abstract

The invention is concerned with aqueous liposome solutions which contain a .beta.-lactamase inhibitor and, if desired, a .beta.-lactam antibiotic.

Drugs covered by this patent

Patent Metadata

Patent number: CA2140701A1
Jurisdiction: CA
Classification: —
Expires: 1995-07-26
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.